| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 44, 716-726, April 2003
Copyright © 2003 by Lipid Research, Inc.
* Department of Cell Chemistry, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan
Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan
Department of Immunochemistry, Faculty of Pharmaceutical Science, Okayama University, Okayama 700-8530, Japan
** Department of Medicine II, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan
Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital London, SE1 7EH, UK
Division of Bioscience, Graduate School of Environment Earth Science, Hokkaido University, Sapporo 060-0810, Japan
*** Program in Cell Biology, Department of Medicine, National Jewish Medical and Research Center, Denver, CO 80206
1 To whom correspondence should be addressed. e-mail: eijimatu{at}md.okayama-u.ac.jp
ß2-glycoprotein I (ß2-GPI) is a major antigen for antiphospholipid antibodies (Abs, aPL) present in patients with antiphospholipid syndrome (APS). We recently reported (J. Lipid Res., 42: 697, 2001; J. Lipid Res., 43: 1486, 2002) that ß2-GPI specifically binds to Cu2+-oxidized LDL (oxLDL) and that the ß2-GPI ligands are 
-carboxylated 7-ketocholesteryl esters. In the present study, we demonstrate that oxLDL forms stable and nondissociable complexes with ß2-GPI in serum, and that high serum levels of the complexes are associated with arterial thrombosis in APS. A conjugated ketone function at the 7-position of cholesterol as well as the -carboxyl function of the ß2-GPI ligands was necessary for ß2-GPI binding. The ligand-mediated noncovalent interaction of ß2-GPI and oxLDL undergoes a temperature- and time-dependent conversion to much more stable but readily dissociable complexes in vitro at neutral pH. In contrast, stable and nondissociable ß2-GPI-oxLDL complexes were frequently detected in sera from patients with APS and/or systemic lupus erythematodes. Both the presence of ß2-GPI-oxLDL complexes and IgG Abs recognizing these complexes were strongly associated with arterial thrombosis. Further, these same Abs correlated with IgG immune complexes containing ß2-GPI or LDL.
Thus, the ß2-GPI-oxLDL complexes acting as an autoantigen are closely associated with autoimmune-mediated atherogenesis.
Abbreviations: Ab, antibody; APS, antiphospholipid syndrome; ß2-GPI, ß2-glycoprotein I; oxLDL, oxidized LDL; PL, phospholipid
Supplementary key words antiphospholipid syndrome • arterial thrombosis • autoantibody
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  P. R. J. Ames, I. Antinolfi, A. Ciampa, J. Batuca, G. Scenna, L. R. Lopez, J. Delgado Alves, L. Iannaccone, and E. Matsuura Primary antiphospholipid syndrome: a low-grade auto-inflammatory disease? Rheumatology, December 1, 2008; 47(12): 1832 - 1837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Soltesz, H. Der, K. Veres, R. Laczik, S. Sipka, G. Szegedi, and P. Szodoray Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction Rheumatology, November 1, 2008; 47(11): 1628 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Matsuura and L. Lopez Autoimmune-mediated atherothrombosis Lupus, October 1, 2008; 17(10): 879 - 888. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Yamaguchi, N. Seta, J. Kaburaki, K. Kobayashi, E. Matsuura, and M. Kuwana Excessive exposure to anionic surfaces maintains autoantibody response to 2-glycoprotein I in patients with antiphospholipid syndrome Blood, December 15, 2007; 110(13): 4312 - 4318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kobayashi, K. Tada, H. Itabe, T. Ueno, P.-H. Liu, A. Tsutsumi, M. Kuwana, T. Yasuda, Y. Shoenfeld, P.G. de Groot, et al. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages Lupus, December 1, 2007; 16(12): 929 - 938. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Franck, H. L. Staub, J. B. Petracco, G. L. Norman, A. J. Lassen, N. Schiavo, R. B. K. Borges, and C. A. von Muhlen Autoantibodies to the Atheroma Component Beta2-Glycoprotein I and Risk of Symptomatic Peripheral Artery Disease Angiology, July 1, 2007; 58(3): 295 - 302. [Abstract] [PDF]
|
|
|
|
|
|
C. Christodoulou, S. Sangle, and D. P. D'Cruz Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome Rheumatology, June 1, 2007; 46(6): 907 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tabuchi, K. Inoue, H. Usui-Kataoka, K. Kobayashi, M. Teramoto, K. Takasugi, K. Shikata, M. Yamamura, K. Ando, K. Nishida, et al. The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis J. Lipid Res., April 1, 2007; 48(4): 768 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M McMahon, J Grossman, W Chen, and B H Hahn Inflammation and the pathogenesis of atherosclerosis in systemic lupus erythematosus Lupus, November 1, 2006; 15(11_suppl): 59 - 69. [Abstract] [PDF]
|
|
|
|
|
|
E Matsuura, K Kobayashi, B. Hurley, and L. Lopez Atherogenic Oxidized Low-Density Lipoprotein/{beta}2-Glycoprotein I (oxLDL/{beta}2GPI) Complexes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome Lupus, July 1, 2006; 15(7): 478 - 483. [Abstract] [PDF]
|
|
|
|
|
|
S I van Leuven, J J. Kastelein, D P D'Cruz, G R Hughes, and E S Stroes Atherogenesis in rheumatology Lupus, March 1, 2006; 15(3): 117 - 121. [Abstract] [PDF]
|
|
|
|
|
|
L R Lopez, M Salazar-Paramo, C Palafox-Sanchez, B L Hurley, E Matsuura, and I Garcia-De La Torre Oxidized low-density lipoprotein and {beta}2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis Lupus, February 1, 2006; 15(2): 80 - 86. [Abstract] [PDF]
|
|
|
|
|
|
I. N. Bruce 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus Rheumatology, December 1, 2005; 44(12): 1492 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P R. Ames, C Tommasino, G Fossati, E Matsuura, A Margarita, A Saulino, L Lopez, G Scenna, and V Brancaccio Lymphocyte subpopulations and intima media thickness in primary antiphospholipd syndrome Lupus, October 1, 2005; 14(10): 809 - 813. [Abstract] [PDF]
|
|
|
|
|
|
E Matsuura, K Kobayashi, K Inoue, L R Lopez, and Y Shoenfeld Oxidized LDL/{beta}2-glycoprotein I complexes: new aspects in atherosclerosis Lupus, September 1, 2005; 14(9): 736 - 741. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Matsunaga and M.-a. Muramatsu Knowledge-based computational search for genes associated with the metabolic syndrome Bioinformatics, July 15, 2005; 21(14): 3146 - 3154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kuwana, E. Matsuura, K. Kobayashi, Y. Okazaki, J. Kaburaki, Y. Ikeda, and Y. Kawakami Binding of {beta}2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells Blood, February 15, 2005; 105(4): 1552 - 1557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Shoenfeld, R. Wu, L. D. Dearing, and E. Matsuura Are Anti-Oxidized Low-Density Lipoprotein Antibodies Pathogenic or Protective? Circulation, October 26, 2004; 110(17): 2552 - 2558. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
